Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F02Q1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,223
Award facts
- Contract value 100% obligated
- $26,222.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $26,222.75 delivery order by the Defense Logistics Agency on December 31, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens in 3ml vials. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. Performance is scheduled for completion by January 2, 2026, at the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 through December 2026.
The DLA Troop Support Medical IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical commodities to military healthcare systems worldwide. AmerisourceBergen's federal contract portfolio demonstrates significant capability across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialty medical supplies. The Defense Logistics Agency manages the medical supply chain for military and veteran healthcare systems, and DLA is planning to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen as a critical vendor supporting the Defense Health Agency and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DR26F02Q1?
SPE2DR26F02Q1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26F02Q1 worth?
The government has obligated $26,223 on SPE2DR26F02Q1.
Is contract SPE2DR26F02Q1 an order under another contract?
Yes. SPE2DR26F02Q1 is a delivery order under SPE2DR25D2200, an indefinite delivery contract.
Was contract SPE2DR26F02Q1 competed?
The extent of competition for SPE2DR26F02Q1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award